Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Andrew Gregory Health editor in Madrid

Weight loss drugs can halve heart patients’ risk of early death, study finds

A woman holding a semaglutide injection.
An expert said more evidence would be required before doctors could recommend rolling out weight loss drugs to heart patients specifically to cut their risk. Photograph: Iuliia Burmistrova/Getty Images

Weight loss drugs can reduce by half the risk of heart patients being hospitalised or dying early, according to the largest study of its kind.

The class of drugs, known as GLP-1 agonists, have been found to offer “dramatic benefits” to heart patients, significantly cutting their risk of falling seriously ill or dying prematurely from any cause.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.